Infection News

An FDA advisory committee recently voted there was adequate data to support the safety and efficacy of fecal microbiota transplant therapy Rebyota for the treatment of adult patients with recurrent Clostridioides difficile infection.

Use of an algorithm-based tool to determine the likelihood of viral etiology for acute diarrhea in children did not significantly reduce antibiotic prescriptions in developing countries, according to a study in JAMA Pediatrics.

As monkeypox case counts continue to expand globally, a series of potentially new clinical symptoms have begun to emerge, a development that may bring gastroenterologists to the forefront of care for this evolving outbreak.

Norovirus outbreaks have rebounded to pre-pandemic levels as COVID-19 mitigation measures have eased around the country, CDC researchers reported on Thursday.

Although the FDA has granted tentative approval to Norwich Pharmaceuticals’ 200 mg generic rifaximin, Bausch Health asserted in a company statement that full approval will not be given until its own rifaximin patent expires in 2029.

Although the prevalence of Clostridioides difficile infection in the U.S. continued its long-term downward trend during the COVID-19 pandemic, patients who were infected saw high treatment costs and increased mortality, a study found.

Use of biologics did not worsen stable SARS-CoV-2 infection in patients with inflammatory bowel disease if given within 2 weeks of virus detection, according to research published in Clinical Gastroenterology and Hepatology.

Healio spoke with John D. Scott, MD, MSc, FIDSA, chief digital health officer at UW Medicine, professor of allergy and infectious diseases at University of Washington and medical director at the Liver Clinic at Harborview Medical Center, to learn more about what PCPs can do to help prevent and screen for HDV.

Splash pads for children at water parks offer less risk for drowning, but inadequate disinfection and poor toileting/hygiene skills create a hub for gastrointestinal illness outbreaks, noted data in Morbidity and Mortality Weekly Report.

Patients treated with alternative antimicrobial prophylaxis for elective colorectal surgery faced higher rates of surgical site infections than patients who received IV beta lactam-based prophylaxis, researchers found.